You've reached the limit for free Overall Ranking scores. For more information, request a demo.
See CSRHub in Action
You have a total of 10 free searches available.
| Low 0-29 | 30-39 | 40-49 | 50-59 | 60-79 | 80-100 High |
Bristol-Myers Squibb is a global pharmaceutical company focused on the discovery, development, and delivery of medicines aimed to help patients with serious diseases. Around the world, Bristol-Myers medicines are used to treat cancer, cardiovascular disease, diabetes, hepatitis B, HIV/AIDS, rheumatoid arthritis, and psychiatric disorders. The Company’s products include Abilify, Atripla, Avapro, Baraclude, Erbitux, Ixempra, Orencia, Onglyza, Plavix, Reyataz, Sprycel, and Sustiva, among others.
| Ticker: | BMY |
| ISIN: | US1101221083 |
| Address: |
345 Park Avenue |
| New York City, NY, 10154, USA | |
| Website: | Bristol-Myers Squibb Company |
| Phone #: | 2125464000 |
| ESG Web Area: | Subscribers Only ? |
| Industry: | Pharmaceutical & Medicine Manufacturing |
We considered many names for our site—in fact we spent our first year and a half under a different name—EkoHub. We liked “Eko” — coming from the Greek word Oikos, related to economy, ecology, and “home” or social concerns. From the beginning, we believed the word “Hub” reflected our desire to be at the center of the sustainability area, providing knowledge, harmony, and consensus among the hundreds of experts judging the ESG performance of companies.